< Back to previous page
Researcher
Peter Witters
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Woman and Child (Division)
Member
From1 Oct 2014 → Today - Hepatology (Division)
Member
From1 Oct 2006 → 30 Sep 2010
Projects
1 - 10 of 10
- A novel hybrid metabolomics platform combining the power of gas chromatography separation with highresolution, high-accuracy mass spectrometry of full precursor masses.From1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Towards treatments of Congenital Disorders of GlycosylationFrom1 Oct 2021 → TodayFunding: FWO fundamental clinical research fellowship
- Metabolomics as a tool for developing therapies in an endothelial cell model of congenital disorders of glycosylationFrom20 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The endothelium is a central mediator of cystic fibrosis lung diseaseFrom20 Nov 2020 → 24 May 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Studying congenital disorders of glycosylation and their potential treatments using tracer metabolomicsFrom24 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Vascular & immune microenvironments in patients with CF-associated liver disease.From3 Sep 2020 → TodayFunding: Other federal public and semi-governmental institutions
- Galactose rewires metabolism in the treatment of congenital disorders of glycosylation.From1 Jan 2020 → TodayFunding: FWO research project
- Mapping and treating metabolic rewiring in mitochondrial diseaseFrom1 Oct 2018 → 13 Jan 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- DE ROL VAN HET ENDOTHEEL IN MUCOVISCIDOSE GEASSOCIEERDE LEVERZIEKTEFrom1 Dec 2017 → 24 Nov 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- The endothelium as the central mediator of cystic fibrosis associated liver disease.From1 Oct 2017 → 30 Sep 2019Funding: Other federal public and semi-governmental institutions
Publications
1 - 10 of 89
- Mapping and treating metabolic rewiring in mitochondrial disease(2023)
Authors: Isabelle Adant, David Cassiman, Pieter Vermeersch, Peter Witters, Bart Ghesquière
- Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results(2022)
Authors: Peter Witters
- Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction(2022)
Authors: Isabelle Adant, Bram Decru, Peter de Witte, Daisy Rymen, Peter Witters, Pieter Vermeersch, David Cassiman, Bart Ghesquière
- Cystic fibrosis and alpha-1 antitrypsin deficiency: case report and review of literature(2022)
Authors: Ilse Hoffman, Noël Knops, Peter Witters, Marijke Proesmans
- Understanding Inborn Errors of Metabolism through Metabolomics(2022)
Authors: Karen Driesen, Peter Witters
- TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disability(2022)
Authors: Peter Witters
Pages: 894 - 904 - Continued improvement in pulmonary, visceral, biomarker and growth outcomes in children with chronic acid sphingomyelinase deficiency treated with olipudase alfa enzyme replacement therapy: 2-year results of ASCEND-Peds(2022)
Authors: Peter Witters
Pages: S37 - S37 - Liver abscesses in the Western pediatric population.(2022)
Authors: Ilse Hoffman, Peter Witters
Pages: 439 - 445 - THE ROLE OF THE ENDOTHELIUM IN CYSTIC FIBROSIS ASSOCIATED LIVER DISEASE(2021)
Authors: Mathias Declercq, Peter Witters, Lucas Treps, Peter Carmeliet
- Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings(2021)
Authors: Matthew Wilson, Erika Souche, Daisy Rymen, Peter Witters, Gert Matthijs
Pages: 2130 - 2144